VenoStent

Houston, TX · Founded 2015 · Privately Held (backing)

Developer of a biomedical engineering technology designed to improve the quality and length of life for dialysis patients. VenoStent is based in Houston, TX and was founded in 2015. It has raised $22.8 million across 2 recorded rounds; the latest was a $10 million early-stage round in Apr 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$22.8M
Last round
Early Stage VC
Apr 2026
Cap table — not yet on record

VenoStent's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of VenoStent with a free account
  • ·The complete investor list: 30 names
  • ·Watch VenoStent: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about VenoStent

Where does VenoStent's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across VenoStent's 2 recorded funding rounds.